Discover 604 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lincoln offers a wide variety of trials focused on numerous chronic conditions like diabetes, mental health disorders, and cardiovascular diseases. Participants, including healthy volunteers seeking paid research opportunities or those with a particular health condition, can explore new treatment options while contributing to the development of groundbreaking therapies.
Filter
2
Filter results
Results: 604
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science
for
Congenital Diaphragmatic Hernia
Location: Omaha NE, St Louis MO, Chicago IL, Dallas TX,
Sponsor: Columbia University
Sex: All
Age: 0+
Code: NCT00950118
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
for
Lennox Gastaut Syndrome
Location: Omaha NE, Roseville MN, Chicago IL, Dallas TX,
Sponsor: Epygenix
Sex: All
Age: 2 - 55
Code: NCT05066217
Phase3, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Omaha NE, Kansas City MO, Sioux Falls SD, Iowa City IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Omaha NE, Kansas City MO, Iowa City IA, Minneapolis MN,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 1
Code: NCT02852031
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Omaha NE, Minneapolis MN, Oklahoma City OK, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Omaha NE, Kansas City MO, Des Moines IA, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Omaha NE, Kansas City MO, Des Moines IA, Wichita KS,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Omaha NE, Kansas City MO, Des Moines IA, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
Validating a Blood Test for the Detection of Traumatic Brain Injury in Children
for
Pediatric Traumatic Brain Injury
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 0 - 17
Code: NCT06940232
Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Omaha NE, Kansas City MO, Des Moines IA, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Omaha NE, Kansas City MO, Des Moines IA, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Omaha NE, Des Moines IA, Sioux Falls SD, Iowa City IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Omaha NE, Des Moines IA, Minneapolis MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase2, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)